ZIKV E Protein (His tag)

Produktnummer ABIN7198750

Produktdetails

Target: ZIKV E (Zika Virus Envelope (ZIKV E))

Protein-Typ: Recombinant

Spezies: Zika Virus (ZIKV)

Quelle: Baculovirus infected Insect Cells

Aufreinigungstag / Konjugat: Dieses ZIKV E Protein ist gelabelt mit His tag.

Verwendungszweck: Recombinant ZIKV (strain Zika SPH2015) Envelope protein ( His Tag)

Sequenz: Ile291-Gly694

Produktmerkmale: A DNA sequence encoding the Zika virus (strain Zika SPH2015) E / Envelope (ALU33341.1) (Ile291-Gly694) was expressed with a polyhistidine tag at the C-terminus.

Reinheit: > 90 % as determined by SDS-PAGE.

Endotoxin-Niveau: < 1.0 EU per μg protein as determined by the LAL method.

Anwendungsinformationen

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Rekonstitution: Please refer to the printed manual for detailed information.

Buffer: Lyophilized from sterile 20 mM Tris, 500 mM NaCl, pH 8.0, 10 % gly. Normally 5 % - 8 % trehalose, mannitol and 0.01 % Tween80 are added as protectants before lyophilization. Please refer to the specific buffer information in the printed manual.

Lagerung: 4 °C,-20 °C,-80 °C

Informationen zur Lagerung: Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80°C. Reconstituted protein solution can be stored at 4-8°C for 2-7 days. Aliquots of reconstituted samples are stable at < -20°C for 3 months.

Antigendetails

Target: ZIKV E (Zika Virus Envelope (ZIKV E))

Andere Bezeichnung: Zika Envelope (ZIKV E Produkte)

Hintergrund:

Background: Envelope of Zika virus is resposible for receptor binding and membrane. Analysis of the envelope protein of Zika, from Brazilian Zika SPH215 (KU321639), indicates predicted B and T cell epitopes in peptides that are consistent to those reported for dengue, YFYF and Japanese encephalitis. The envelope Domain II B cell epitope, to which much dengue non-neutralizing cross reaction is attributed, is also conserved also in Zika virus, consistent with prior field observations of cross reactivity with dengue and YF. Domain III of the Zika envelope protein, likely the main specific neutralizing domain, is distinct from recent Brazilian dengue isolates and a recent Peruvian YF isolate (GQ379163), 76 % of possible major histocompatibility complex class (MHC) I and MHC II binding peptides and potential B cell linear epitopes are unique to Zika virus.

Synonym: Zika virus, E protein, strain Zika SPH2015

Molekulargewicht: 45.5kDa.